Futura has signed licensing agreements with global leading distributors for two of its leading products under development and is in discussions on the other products.
Our strategy is to license the products during their development to established pharmaceutical and healthcare groups which offer the best potential commercial opportunities.
The table below shows which products are licensed/not available and which ones are therefore available for licensing.
| Product | UK | EU | USA | Rest of world |
| CSD500 | Not available | Not available | Not available | Not available |
 |
|
|
|
|
| MED2002 | Not available | Not available | Not available | Not available |
|
|
|
|
|
| TPR100 | Available | Available | Available | Available |
|
|
|
|
|
| PET500 | Available | Available | Available | Available |
|
|
|
|
|
| RAD100 | Available | Available | Available | Available |
If you are interested in licensing a product please contact us.
Although we initiate and develop our product range internally, we are very interested to hear from organisations with product concepts or technologies related to Futura's areas of focus. Our focus remains on topical pharmaceutical drugs and medical devices that incorporate existing chemical entities and which can be sold over the counter.
If you wish to contact us, please write to us at Futura Medical Developments Limited, Surrey Technology Centre, 40 Occam Road, Guildford, Surrey, GU2 7YG or email us at info@futuramedical.com.